BHAGCHEM.NS BHAGCHEM NSE
₹247.65
-18.48% 1Y
Market & Price
Market Cap
-
Current Price
₹247.65
High / Low (52W)
₹311.28 / ₹171.47
Beta
-
Valuation
Stock P/E
-
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
₹-
Price to Book
-
P/S
-
EV/EBITDA
-
Dividend Yield
-
Profitability & Returns
ROCE
4.41%
ROE
-
ROA
-
Profit Margin
-
Op Margin
-
EPS (Latest Qtr)
₹0.31
EPS (TTM)
₹-
Balance Sheet & Liquidity
Debt/Equity
-
Quick Ratio
-
Current Ratio
-
Debt
-
Total Assets
₹1,120.19 Cr
Current Assets
₹436.49 Cr
Working Capital
₹190.95 Cr
Ownership
Promoter Holding
-
Chg in Prom Hold
-
FII / Inst Holding
-
Chg in FII Hold
-
Financial Snapshot
Enterprise Value
-
Total Revenue (TTM)
-
EBITDA
-
Free Cash Flow
-
Operating Cash Flow
-
Shares Outstanding
-
Gross Margin
-
Payout Ratio
-
Growth (CAGR)
Revenue 5Y
2.20%
Profit 5Y
-26.17%
Revenue (YoY)
-
Earnings (YoY)
-
PROS
No notable strengths flagged.
CONS
- Earnings shrank at -26.2% CAGR over 5 years.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Ad space
Quarterly Results
Figures in INR.
| Metric | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Revenue | - | 102.73 Cr | 122.62 Cr | 123.78 Cr | 140.10 Cr | 113.97 Cr | 158.10 Cr |
| Cost of Revenue | - | 61.79 Cr | 83.70 Cr | 82.25 Cr | 91.35 Cr | 65.00 Cr | 96.58 Cr |
| Gross Profit | - | 40.94 Cr | 38.92 Cr | 41.52 Cr | 48.75 Cr | 48.97 Cr | 61.52 Cr |
| Operating Expenses | - | 35.39 Cr | 36.44 Cr | 36.40 Cr | 37.64 Cr | 40.18 Cr | 50.33 Cr |
| Operating Income | - | 5.55 Cr | 2.48 Cr | 5.12 Cr | 11.10 Cr | 8.80 Cr | 11.18 Cr |
| EBITDA | - | 11.61 Cr | 7.39 Cr | 9.63 Cr | 15.52 Cr | 14.26 Cr | 20.09 Cr |
| Interest Expense | - | 2.45 Cr | 1.55 Cr | 3.26 Cr | 4.06 Cr | 3.10 Cr | 7.05 Cr |
| Pretax Income | - | 5.55 Cr | 2.25 Cr | 2.50 Cr | 7.51 Cr | 6.29 Cr | 4.81 Cr |
| Tax Provision | - | 1.96 Cr | 3.13 Cr | -1.48 Cr | 2.00 Cr | 1.67 Cr | 73.63 L |
| Net Income | - | 3.59 Cr | -88.42 L | 3.98 Cr | 5.50 Cr | 4.62 Cr | 4.07 Cr |
| Diluted EPS | 0.42 | 0.26 | -0.08 | 0.32 | 0.42 | 0.36 | 0.31 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | - | 502.00 Cr | 407.50 Cr | 440.47 Cr | 535.94 Cr |
| Cost of Revenue | - | 381.32 Cr | 315.92 Cr | 278.13 Cr | 335.18 Cr |
| Gross Profit | - | 120.68 Cr | 91.58 Cr | 162.35 Cr | 200.76 Cr |
| Operating Expenses | - | 53.01 Cr | 59.49 Cr | 139.26 Cr | 164.55 Cr |
| Operating Income | - | 67.67 Cr | 32.09 Cr | 23.08 Cr | 36.21 Cr |
| EBITDA | - | 76.02 Cr | 43.18 Cr | 46.23 Cr | 59.50 Cr |
| Interest Expense | - | 2.43 Cr | 5.27 Cr | 7.11 Cr | 17.46 Cr |
| Pretax Income | - | 63.78 Cr | 26.92 Cr | 25.25 Cr | 21.11 Cr |
| Tax Provision | - | 18.63 Cr | 8.70 Cr | 11.39 Cr | 2.93 Cr |
| Net Income | - | 45.15 Cr | 18.22 Cr | 13.86 Cr | 18.17 Cr |
| Diluted EPS | - | 4.43 | 1.61 | 1.14 | 1.10 |
Compounded Sales Growth
| 5 Years: | 2.20% |
| 1 Year: | - |
Compounded Profit Growth
| 5 Years: | -26.17% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | -18.48% |
| 6 Months: | -3.21% |
| 3 Months: | +20.58% |
| 1 Month: | -7.80% |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Total Assets | - | 446.91 Cr | 576.04 Cr | 933.15 Cr | 1,120.19 Cr |
| Current Assets | - | 228.25 Cr | 280.31 Cr | 374.88 Cr | 436.49 Cr |
| Cash & Equivalents | - | 2.94 Cr | 9.35 Cr | 28.23 Cr | 16.35 Cr |
| Inventory | - | 91.32 Cr | 111.49 Cr | 129.71 Cr | 145.75 Cr |
| Receivables | - | 128.77 Cr | 107.10 Cr | 173.86 Cr | 204.68 Cr |
| Total Liabilities | - | 133.66 Cr | 162.33 Cr | 250.93 Cr | 421.87 Cr |
| Current Liabilities | - | 100.75 Cr | 125.52 Cr | 195.26 Cr | 245.54 Cr |
| Long Term Debt | - | 16.57 Cr | 16.94 Cr | 30.05 Cr | 153.14 Cr |
| Total Debt | - | 50.20 Cr | 61.64 Cr | 88.91 Cr | 234.64 Cr |
| Total Equity | - | 313.25 Cr | 413.71 Cr | 682.22 Cr | 698.32 Cr |
| Shares Outstanding | - | 10.41 Cr | 10.41 Cr | 12.97 Cr | 12.97 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 13.89 Cr | 34.29 Cr | -52.80 Cr | 12.01 Cr |
| Investing Cash Flow | - | -59.61 Cr | -115.62 Cr | -200.56 Cr | -160.17 Cr |
| Financing Cash Flow | - | 46.47 Cr | 88.31 Cr | 271.66 Cr | 136.28 Cr |
| Capital Expenditure | - | -59.83 Cr | -79.05 Cr | -252.28 Cr | -160.14 Cr |
| Free Cash Flow | - | -45.93 Cr | -44.77 Cr | -305.08 Cr | -148.12 Cr |
| Net Change in Cash | - | 74.62 L | 6.98 Cr | 18.30 Cr | -11.88 Cr |
Ratios (Annual)
Figures in %.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Margin % | - | 24.0% | 22.5% | 36.9% | 37.5% |
| Operating Margin % | - | 13.5% | 7.9% | 5.2% | 6.8% |
| Net Margin % | - | 9.0% | 4.5% | 3.1% | 3.4% |
| ROE % | - | 14.4% | 4.4% | 2.0% | 2.6% |
| ROCE % | - | 19.5% | 7.1% | 3.1% | 4.1% |
Analyst View
Loading analyst coverage…
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for BHAGCHEM
No recent headlines available.